Home / Technology / Huawei's Smartwatches Monitor Heart Health at Global Conferences
Huawei's Smartwatches Monitor Heart Health at Global Conferences
18 Nov
Summary
- Huawei wearables recognized at international medical conferences.
- Research cited in Asia Pacific Atrial Fibrillation Guidelines.
- New blood pressure monitoring innovations showcased in Dubai.
Huawei's commitment to cardiovascular health research is being highlighted at major international medical conferences. Wearable device studies were presented at the 19th Asia Pacific Heart Rhythm Society Scientific Session in South Korea and the 31st International Society of Hypertension Scientific Meeting in Dubai. Research involving Huawei wearables was notably cited within the 2026 Asia Pacific Atrial Fibrillation Guidelines, underscoring the growing role of smart devices in proactive heart health monitoring.
At the ISH conference in Dubai, Huawei also introduced its latest advancements in blood pressure monitoring. This included the HUAWEI WATCH D3 and a new Minimally Disruptive Ambulatory Blood Pressure Monitoring initiative developed with Ruijin Hospital. The goal is to create more comfortable and practical long-term blood pressure monitoring solutions.
The HUAWEI WATCH D3 and GT 7 Pro offer a one-tap Health Glance assessment, analyzing key indicators like heart rate, HRV, blood oxygen, and ECG. While these features are for general wellness and not medical devices, Huawei aims to make heart and blood pressure care more accessible through continued innovation and global research collaborations.